Metoclopromide is a dopamine antagonist that acts on dopamine receptors in both the chemoreceptor zone and the gastrointestinal tract. Metoclopromide has been administered prophylactically, in addition to a standard antiemetic regimen, at 20 mg per day on days 2–5 following cisplatin chemotherapy.